BIOMAT Database Logo BIOMAT Database Logo

Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation. 2013

Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
University Heart Center Hamburg, Hamburg, Germany.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001897 Boronic Acids Inorganic or organic compounds that contain the basic structure RB(OH)2. Boronic Acid,Acid, Boronic,Acids, Boronic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069286 Bortezomib A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. LDP-341,PS 341,PS-341,Velcade,341, PS,LDP 341,LDP341,PS341
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience.
January 2010, Clinical transplants,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
October 2019, Transplantation direct,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation.
January 2010, Clinical transplants,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Antibody-mediated rejection after lung transplantation.
March 2020, Annals of translational medicine,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
March 2012, Clinical nephrology,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Acute antibody-mediated rejection after lung transplantation.
October 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Acute antibody-mediated rejection after lung transplantation.
January 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.
November 2015, Yonsei medical journal,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Bortezomib for acute antibody-mediated rejection in liver transplantation.
September 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Christina Baum, and Hermann Reichenspurner, and Tobias Deuse
Cyclophosphamide rescue therapy for chronic rejection after lung transplantation.
November 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Copied contents to your clipboard!